Tarsus Pharmaceuticals Competitors and Similar CompaniesClear all
Biogen's competitors and similar companies include Ipsen and CSL Behring.
 Biogen Biogen (formerly known as Biogen Idec) is a biopharmaceutical company that develops and delivers therapies for neurological and neurodegenerative diseases. | |||
Founding Date | Founding Date 1978 | Founding Date 1929 | Founding Date 1904 |
Type | Type Public | Type Public | Type Subsidiary |
Tags | |||
Locations | Locations Cambridge, US HQ Vicente López, AR Macquarie Park, AU Wien, AT Machelen, BE São Paul, BR Toronto, CA see more | Locations Boulogne-Billancourt, FR HQ Algiers, DZ South Yarra, AU Wien, AT Merelbeke, BE São Paulo, BR Mississauga, CA see more | Locations King of Prussia, US HQ Broadmeadows, AU Parkville, AU Parkville, AU Wien, AT Mechelen, BE see more |
Employees | Employees 7,605 | Employees 5,358 | Employees 7,5692% decrease |
Valuation ($) | Valuation ($) 26.7 b | Valuation ($) 10.2 b | Valuation ($) N/A |
Financial | |||
Revenue (est.) | Revenue (est.) $9.9b (FY, 2025) | Revenue (est.) €3.7b (FY, 2025) | Revenue (est.) $7.9b (FY, 2020) |
Cost of goods | Cost of goods $2.4b (FY, 2025) | Cost of goods €659.1m (FY, 2025) | Cost of goods N/A |
Gross profit | Gross profit $7.5b (FY, 2025) | Gross profit €3.3b (FY, 2025) | Gross profit $4.5b (FY, 2020) |
Net income | Net income $1.3b (FY, 2025) | Net income €445.1m (FY, 2025) | Net income N/A |
For sources of this data, please see the company profile